Developing an efficient catalyst for the electrocatalytic CO 2 reduction reaction (CO 2 RR) is highly desired because of environmental and energy issues. Herein, we report a single-atomic-site Cu catalyst supported by a Lewis acid for electrocatalytic CO 2 reduction to CH 4 . Theoretical calculations suggested that Lewis acid sites in metal oxides (e.g., Al 2 O 3 , Cr 2 O 3 ) can regulate the electronic structure of Cu atoms by optimizing intermediate absorption to promote CO 2 methanation. Based on these theoretical results, ultrathin porous Al 2 O 3 with enriched Lewis acid sites was explored as an anchor for Cu single atoms; this modification achieved a faradaic efficiency (FE) of 62% at −1.2 V (vs RHE) with a corresponding current density of 153.0 mA cm −2 for CH 4 formation. This work demonstrates an effective strategy for tailoring the electronic structure of Cu single atoms for the highly efficient reduction of CO 2 into CH 4 . KEYWORDS: CO 2 RR, Lewis acid, Al 2 O 3 , single-atom Cu catalyst, CH 4
Through deposition of APTES-functionalized Al2O3 particles onto a coarse macroporous support, a new strategy to reduce the pore size and simutaneously promote a high density of heterogeneous nucleation sites was developed, and a continuous and thin ZIF-8 membrane exhibiting remarkably high H2 permeance of 5.73 × 10(-5) mol m(-2) s(-1) Pa(-1) and H2/N2 ideal selectivity of 15.4 was achieved.
Spare capacity: A SnO2/graphene nanocomposite is fabricated by a novel solvothermal method (see picture). The nanocomposite exhibits a reversible lithium storage capacity of 838 mAh g−1 in the first cycle and improved cyclability as an anode material for lithium‐ion batteries.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.